SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif. & ...
Agilent Technologies Inc. and Cogenics, a division of Clinical Data, Inc. have announced that Cogenics has been recertified, for the third year, as a Certified Microarray Service Provider for Agilent ...
PALO ALTO, Calif., July 18, 2006, Agilent Technologies Inc. (NYSE: A) today announced the availability of its new SurePrint microarrays, which contain more than 240,000 features. These DNA microarrays ...
PALO ALTO, Calif., Aug. 7, 2006, Agilent Technologies Inc. (NYSE: A) today announced the availability of oligo array-based ChIP-on-chip (chromatin immunoprecipitation on a chip) microarrays with a ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...
The Microarray Core Facility is a component of the UAlbany Center for Functional Genomics and was established to provide the infrastructure to enable the development of major projects that utilize DNA ...